| abstract |
ABSTRACT The combination of an aromatase-inhibitor with an antiandrogen for use in a method of prophylaxis and/or of treatment by therapy of prostatic hyperplasia, and pharmaceutical preparations and packs suitable for such a use. An aromatase-inhibitor and an antiandrogen in a weight ratio of aromatase-inhibitor to antiandrogen of 20:1 to 1:1 for use in a method of prophylaxia and/or of treatment by therapy of prostatic hyperplasia, and pharma-ceutical preparations and packs suitable for such a use comprising an aromatase-inhibitor and an antiandrogen 1 the aforesaid weight ratio. The aromatase-inhibitor is, for example, testolactone and the antiandrogen is, for example, cyproterone acetate, |